Seeking Alpha

NuVasive (NUVA) jumps 11.7% after disclosing that preliminary 2012 revenues climbed 15% to...

NuVasive (NUVA) jumps 11.7% after disclosing that preliminary 2012 revenues climbed 15% to $619M, above previous guidance of $601-606M and analyst consensus of $604.4M. NuVasive expects 2013 sales of $655M vs Street forecasts of $638.16M. "We anticipate that our market share taking strategy and momentum can be sustained in 2013," says CEO Alex Lukianov, who's due to present at the JPM Healthcare conference today. (PR)

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs